12/21
Headlines

Alnylam Pharmaceuticals

Volatile Stocks: Prosensa Holding (NASDAQ:RNA), 22nd Century Group Inc (NYSEMKT:XXII), Alnylam Pharmaceuticals (NASDAQ:ALNY), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)

Colin Pettis03 mins

Prosensa Holding NV (NASDAQ:RNA) was upgraded by stock analysts at KBC Securities from a “hold” rating to an “accumulate” rating in a report issued on Wednesday. The firm currently has a $11.00 price objective on the stock, up from their previous price objective of $7.00. KBC Securities’ target price would indicate a potential upside of…

Read More

Mid Cap Bullish Stocks : Puma Biotechnology Inc (NYSE:PBYI), J2 Global Inc (NASDAQ:JCOM), Alnylam Pharmaceuticals (NASDAQ:ALNY), athenahealth (NASDAQ:ATHN)

Chris Lewis02 mins

Puma Biotechnology Inc (NYSE:PBYI), a development stage biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will present an overview of the Company at 11:20 a.m. PDT on Wednesday, May 14, at the Bank of America Merrill Lynch 2014 Health Care Conference. The conference will be held at…

Read More

Mix Sector Stocks News: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), Wipro Ltd. (NYSE:WIT), Franco-Nevada Corporation (NYSE:FNV), ICF International Inc. (NASDAQ:ICFI), Avnet, Inc. (NYSE:AVT)

John Meady02 mins

On Jan 20, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), announced that it has commenced an underwritten public offering of shares of its common stock to raise aggregate proceeds of approximately $450 million. All of the shares in the offering are to be sold by Alnylam. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) belongs to Healthcare sector. Its weekly performance is…

Read More